Vasoactive intestinal polypeptide modulates GABAA receptor function through activation of cyclic AMP

Area of Science:

• Neuroscience
• Cellular Signaling
• Ophthalmology

Background:

• Vasoactive intestinal polypeptide (VIP) is known to modulate GABAA receptor activity in retinal ganglion cells.
• The precise intracellular mechanisms underlying VIP's potentiation of GABAA receptor currents remain incompletely understood.

Purpose of the Study:

• To investigate the intracellular signaling cascade mediating VIP's potentiation of GABAA receptor currents in rat retinal ganglion cells.
• To determine the role of the cyclic AMP (cAMP) pathway and protein kinase A (PKA) in this heteroreceptor cross-talk.

Main Methods:

• Utilized intracellular dialysis techniques with guanine nucleotide analogs (GTPγS, GDPβS) in freshly dissociated rat retinal ganglion cells.
• Employed toxins (cholera toxin, pertussis toxin) to probe the involvement of G-proteins and adenylate cyclase.
• Administered forskolin, 8-bromo-cyclic AMP, and PKA directly or indirectly to assess the role of the cAMP/PKA pathway.

Main Results:

• GTPγS potentiated GABAA currents, while GDPβS blocked VIP-induced potentiation, suggesting G-protein involvement.
• Cholera toxin abolished VIP's potentiation, indicating a stimulatory G-protein (Gs) and adenylate cyclase activation.
• Forskolin, 8-bromo-cyclic AMP, and intracellular cAMP application mimicked VIP's effect, and PKA activation potentiated currents, while PKA inhibition blocked VIP's action.

Conclusions:

• VIP modulates GABAA receptor function in retinal ganglion cells through a cascade involving Gs protein and adenylate cyclase.
• The cyclic AMP (cAMP)/protein kinase A (PKA) second-messenger system is essential for mediating VIP's potentiation of GABAA receptor activity.
• This study elucidates a key intracellular signaling pathway for VIPergic modulation in the retina.